January 4, 2024 – “Our relationship with OraSure is a significant milestone for Sapphiros, and we are excited to partner with an organization that shares our focus on expanding access to diagnostic insights. We believe OraSure’s existing commercial infrastructure will allow us to quickly and efficiently scale following regulatory approvals to the populations that need them the most,” said Mark Gladwell, President and CEO of Sapphiros. “We are looking forward to an innovation-filled future that will have a real impact on global health.”